Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neuroverse is a private neurotechnology and digital health company developing wearable brain-interface solutions for brain health and cognitive performance. Its flagship product, BrainStation, combines electroencephalography, actigraphy, and analytics to assess cognitive and emotional states and support neurocognitive assessment, training, and intervention programs. The company positions its platform across healthcare, human performance, and defense applications, with use cases spanning brain assessment, predictive modeling, mindfulness and neurofeedback-based interventions, and remote brain health management. Neuroverse appears to operate primarily as a platform and product company rather than a therapeutics developer, and its offerings are centered on hardware-enabled digital biomarkers and software applications rather than drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuroverse.